Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Clearside Biomedical, Inc. (CLSD) had Gross Margin of 95.68% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$8.23M |
|
$-32.48M |
|
$0.35M |
|
$7.87M |
|
$33.07M |
|
$-24.84M |
|
$-7.64M |
|
$-32.48M |
|
$-32.48M |
|
$-32.48M |
|
$-32.48M |
|
$-32.48M |
|
$-32.48M |
|
$-24.84M |
|
$-24.78M |
|
61.81M |
|
61.81M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$30.12M |
|
$3.00M |
|
$3.90M |
|
$34.02M |
|
$6.81M |
|
-- |
|
$43.12M |
|
$49.93M |
|
$-15.91M |
|
$-15.91M |
|
$-15.91M |
|
62.85M |
|
| Cash Flow Statement Financials | |
$-18.14M |
|
$-1.78M |
|
$0.41M |
|
$48.42M |
|
$28.92M |
|
$-19.50M |
|
$4.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
95.68% |
-302.02% |
|
-302.02% |
|
-301.20% |
|
-394.91% |
|
-394.91% |
|
$-19.91M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
48.39 |
|
7.54 |
|
204.15% |
|
204.15% |
|
-95.49% |
|
204.15% |
|
$-0.25 |
|
$-0.32 |
|
$-0.29 |
|